[Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003918:Dextrothyroxine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use*; D010636:Phenols / Q000627:therapeutic use; D010919:Placebos; D011422:Propionates / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D009281:Naphthalenes; D010636:Phenols; D010919:Placebos; D011422:Propionates; D014280:Triglycerides; D003918:Dextrothyroxine; D002784:Cholesterol
Evaluación clínica de una nueva droga (CH 13437) en el tratamiento de la hiperlipemia.